T. van der Kwast

A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.

H. G. van der Poel, T. H. van der Kwast, R. V. D. van den Bergh, 2021, European urology oncology.

The trade-off between sensitivity and specificity of clinical protocols for identification of insignificant prostate cancer.

T. van der Kwast, 2012, European urology.

Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer.

T. H. van der Kwast, M. Gallee, F. Schroeder, 1989, The Journal of urology.

Different PSA assays lead to detection of prostate cancers with identical histological features.

B. G. Blijenberg, T. H. van der Kwast, C. Bangma, 2002, European urology.